BIRC5 and neoplasm: Coexpression of Survivin and CD44+, in combination with epithelial mesenchymal transition (EMT) markers were indicative of recurrence and aggressive tumor behavior in rectal cancer patients subjected to preoperative radio and chemotherapy [70].